Literature DB >> 16247227

The role of transanal endoscopic microsurgery for rectal tumors.

Hideyuki Suzuki1, Kiyonori Furukawa, Hayato Kan, Hiroyuki Tsuruta, Satoshi Matsumoto, Yukihiro Akiya, Seiichi Shinji, Takashi Tajiri.   

Abstract

PURPOSE: The management of rectal tumors is complex, because of the balance between preserving rectoanal function and curing the patient. Transanal endoscopic microsurgery (TEM) is both an effective treatment for benign rectal tumors and early cancers, and a diagnostic tool for determining tumor depth, or for residual tumors of post endoscopic mucosal resection. In the present study, we evaluated the role of TEM in the management of rectal tumors.
METHODS: Twenty-six patients with rectal tumors underwent TEM from December 2000 through March 2005 in our department. The operations were performed by a single surgeon, and the indications were mainly limited to a) benign tumors for which endoscopic resection was difficult, b) early cancers that had invaded the submucosa within 500 microm of the muscularis mucosae, c) submucosal tumors, i.e., gastrointestinal stromal tumor, carcinoid tumors, d) local excision for diagnosis, and e) palliative resection for high-risk cases. Anesthesia, operation time, sizes of the tumor and of resected specimens, postoperative complications, length of hospitalization, pathological results, and postoperative recurrence rate were reviewed.
RESULTS: The mean age of patients was 61.9 years, and the cases included 14 rectal cancers, 7 adenomas, 1 gastrointestinal stromal tumor, and 3 rectal carcinoid tumors. The mean operation time was 96 min (range, 40 approximately 235 min.). The average postoperative hospital stay was 4.8 days. All tumors were resected with horizontal and vertical safety margin. The mean size of the resected specimens was 9.0 cm(2). In one case, the tumor had infiltrated the proper muscle layer, as shown by intraoperative frozen sectioning, which necessitated abdominoperineal resection. In 3 cases, pathological examination revealed massive infiltration into the submucosal layer. 2 patients underwent low anterior resection, and the remaining patient refused additional surgery despite our recommendation. No deaths occurred. No major postoperative complications were noted. The mean follow-up period was 27.2 months. Only one case of lymph node metastasis was observed, in the left iliac lymph node 3 years after TEM.
CONCLUSIONS: TEM is a minimally invasive surgical procedure for rectal tumors, which allows the whole depth of the rectal wall to be resected with a safety surgical margin. Although TEM requires technical skill and accurate preoperative diagnosis, the procedure is safe, facilitates accurate diagnosis of tumor depth, and limits the need for additional surgery.

Entities:  

Mesh:

Year:  2005        PMID: 16247227     DOI: 10.1272/jnms.72.278

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  8 in total

1.  Transanal endoscopic operation for rectal lesions using two-dimensional visualization and standard endoscopic instruments: a prospective cohort study and comparison with the literature.

Authors:  D H Nieuwenhuis; W A Draaisma; G H M Verberne; A J van Overbeeke; E C J Consten
Journal:  Surg Endosc       Date:  2008-04-29       Impact factor: 4.584

2.  Endoscopic submucosal dissection for laterally spreading tumors in the rectum ≥40 mm.

Authors:  X W Tang; Y T Ren; J Q Zhou; Z J Wei; Z Y Chen; B Jiang; W Gong
Journal:  Tech Coloproctol       Date:  2016-04-06       Impact factor: 3.781

3.  Endoscopic submucosal dissection (ESD) versus transanal endoscopic microsurgery (TEM) for treatment of rectal tumors: a comparative systematic review and meta-analysis.

Authors:  Thomas R McCarty; Ahmad Najdat Bazarbashi; Kelly E Hathorn; Christopher C Thompson; Hiroyuki Aihara
Journal:  Surg Endosc       Date:  2019-07-10       Impact factor: 4.584

4.  Circumferential submucosal incision prior to endoscopic mucosal resection provides comparable clinical outcomes to submucosal dissection for well-differentiated neuroendocrine tumors of the rectum.

Authors:  Dae Young Cheung; Soo Kyoung Choi; Hyung-Keun Kim; Sung Soo Kim; Hiun-Suk Chae; Kyung Jin Seo; Young-Seok Cho
Journal:  Surg Endosc       Date:  2014-10-03       Impact factor: 4.584

Review 5.  Transanal endoscopic microsurgery: a review.

Authors:  Behrouz Heidary; Terry P Phang; Manoj J Raval; Carl J Brown
Journal:  Can J Surg       Date:  2014-04       Impact factor: 2.089

6.  Approach to rectal cancer surgery.

Authors:  Terence C Chua; Chanel H Chong; Winston Liauw; David L Morris
Journal:  Int J Surg Oncol       Date:  2012-06-25

7.  Initial application of transanal endoscopic microsurgery for high-risk lower rectal gastrointestinal stromal tumor after imatinib mesylate neoadjuvant chemotherapy: A case report.

Authors:  Qiaofei Liu; Guangxi Zhong; Weixun Zhou; Guole Lin
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

8.  Comparison of efficacy and safety between endoscopic submucosal dissection and transanal endoscopic microsurgery for the treatment of rectal tumor.

Authors:  Yun Jung; Jun Lee; Ju Yeon Cho; Young Dae Kim; Chan Guk Park; Man Woo Kim; Kyung Jong Kim; Se Won Kim
Journal:  Saudi J Gastroenterol       Date:  2018 Mar-Apr       Impact factor: 2.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.